Explore how immune checkpoint inhibitors are transforming melanoma treatment through immunotherapy breakthroughs, combination strategies, and emerging cellular therapies.
Explore how CDKN2A gene mutations disrupt cell cycle regulation and drive melanoma development through inherited and acquired genetic changes.